熱門資訊> 正文

Inovio Pharmaceuticals 2025年第三季度盈利预览

2025-11-10 06:35

伊諾維奧製藥(INO) 0

Inovio Pharmaceuticals (INO) is scheduled to announce Q3 earnings results on Monday, November 10th, after market close.
The consensus EPS Estimate is -$0.48 (+46.1% Y/Y)Over the last 2 years, INO has beaten EPS estimates 50% of the time and has beaten revenue estimates 25% of the time.
Over the last 3 months, EPS estimates have seen 4 upward revisions and 1 downward. Revenue estimates have seen 0 upward revisions and 1 downward.

More on Inovio Pharmaceuticals

Inovio Pharmaceuticals, Inc. (INO) Presents At H.C. Wainwright 27th Annual Global Investment Conference (Transcript)
Inovio: Back On Track With INO-3107 BLA For RRP Before End Of 2025
Inovio says FDA agrees with rolling BLA submission for rare disease asset

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。